Intraprocedural Determination of Myocardial Vitality Using 2 Different Imaging Methods
Launched by RWTH AACHEN UNIVERSITY · Aug 29, 2013
Trial Information
Current as of June 05, 2025
Unknown status
Keywords
ClinConnect Summary
Each patient with typical angina pectoris symptoms will get echocardiographic examination during the inclusion phase. If motion disorder of regional left ventricular myocardial wall is detected, patient will get coronary angiography (not study related, caused of typical angina pectoris symptoms and high probability of CHD). If coronary stenosis related to motion disorder is available, patient will be randomized in two groups during coronary angiography.
* First Group: Patient will get echocardiographic examination during coronary angiography. 2D-Strain Analysis will be performed based on d...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Typical angina pectoris symptoms
- • Echocardiographic determination of regional motion disfunction of left ventricular wall
- • Establishment of needly treatment of stenosis related to motion disorder based on coronar angiography.
- • Feasibility of MRI-Examination.
- • Patients which are legally competent and which are mentally able to understand the study staff
- • Patients give their written consent
- Exclusion Criteria:
- • Allergy against contrast agent
- • Patients with limited renal function(GFR \< 60 ml/min)
- • Acute or instable angina pectoris
About Rwth Aachen University
RWTH Aachen University is a prestigious research institution located in Aachen, Germany, renowned for its commitment to advancing science and technology through innovative research and education. As a clinical trial sponsor, RWTH Aachen University leverages its interdisciplinary expertise and state-of-the-art facilities to conduct cutting-edge clinical research aimed at improving patient outcomes. The university collaborates with various healthcare stakeholders to facilitate the translation of scientific discoveries into effective therapeutic interventions, ensuring adherence to ethical standards and regulatory requirements throughout the research process. With a focus on fostering knowledge exchange and driving clinical advancements, RWTH Aachen University plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aachen, Nrw, Germany
Patients applied
Trial Officials
Michael Becker, MD
Principal Investigator
University Hospital, Aachen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials